Vertex Pharmaceuticals Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VX1.DE | 095700.KQ | CSL.AX | KRYS | ROIV | 1530.HK | |
|---|---|---|---|---|---|---|
| Market cap | 123.35B | 94.14B | 97.13B | 9.21B | 27.61B | 37.99B |
| P/E (TTM) | 36.4 | — | — | 42.2 | — | 4.1 |
| Forward P/E | — | — | 21.5 | 34.0 | -27.5 | 11.2 |
| Price/book | 6.6 | — | 4.6 | 6.4 | 6.5 | 1.2 |
| Dividend yield | — | — | 2.05% | — | — | 1.69% |
| 1-year change | +29.93% | −60.56% | +11.91% | +55.44% | +85.85% | −51.32% |
| Today | +0.72% | +0.73% | +2.56% | +1.90% | +6.08% | +4.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All VX1.DE news ›H.C. Wainwright Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
The Globe and Mail In a report released today, Ananda Ghosh from H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $641.00. Ghosh covers the Healthcare sector, focusing on stocks such
Vertex Pharmaceuticals (VRTX) Receives a Buy from TD Cowen
The Globe and Mail In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $575.00. According to TipRanks, Nadeau is a 4-star analyst with an average return of 6.0% and
Vertex Pharmaceuticals Incorporated 2026 Q3 - Results - Earnings Call Presentation
2026-11-05. The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2026 Q3 earnings call. The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with…
Vertex Pharmaceuticals Thrives on Higher Sales and Guidance
Since 2008, Vertex Pharmaceuticals, Inc. (VRTX) shares have received 43 outlier institutional inflow signals and gained over 1,738%. It’s no wonder VRTX shares are up 17% so far this year – and they could rise more. MoneyFlows data shows…
Vertex Pharmaceuticals Incorporated $VRTX Stock Acquired by Vise Technologies Inc.
Posted by Danessa Lincoln on Nov 4th, 2026 NASDAQ:VRTX opened at $530.76 on Wednesday. Vertex Pharmaceuticals Incorporated has a 52 week low of $403.16 and a 52 week high of $568.67. The firm has a 50 day moving average of $522.98 and a…
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.61% on Nov 3: Drivers Behind the Movement
Vertex Pharmaceuticals Inc (VRTX) moved down by 3.61%. The Pharmaceuticals & Medical Research sector is down by 0.27%. The company underperformed the industry. Top 3 stocks by turnover in the sector: Eli Lilly and Co (LLY) up 0.50%; Pfizer…
UBS maintains Vertex Pharmaceuticals at Buy, raises price target to $640 from $615
UBS maintained Vertex Pharmaceuticals at Buy and raised its price target to $640 from $615, a 4.1% increase. The price target implies an upside of 15.7% from the Nov 2 close of $553.15. Recent analyst actions on Vertex Pharmaceuticals…
How Is Vertex Pharmaceuticals (NASDAQ:VRTX) Expanding Beyond Its Core Business?
S&P 500 Evening Wrap 03-11-2026: Canola Down, ADM In Focus, What Next? What Changes Now That Wells Fargo (NYSE:WFC) Can Expand Again? Beyond acute pain, the same mechanism is being studied in chronic conditions such as nerve-related pain,…
Vertex Pharmaceuticals Non-GAAP EPS of $4.76 misses by $0.02, revenue of $3.44B beats by $10M
Vertex’s financial guidance is summarized below: $13.15 to $13.25 billion vs consensus of $13.28B $13.1 to $13.2 billion $0.5 billion or greater $40 to $50 million $7.15 to $7.2 billion $6.3 to $6.45 billion $5.65 to $5.75 billion
Vertex Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $592.56, Implies 7% Upside
TradingView Vertex Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $592.56, Implies 7% Upside - According to estimates from 27 analysts, Vertex Pharmaceuticals Incorporated stock'
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com30
- fool.com6
- theglobeandmail.com6
- themarketsdaily.com6
- seekingalpha.com5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 82 articles, not a forecast.